Search

everythinglearnresearchcommunity

for

Search:↓

The document provides ways to tell alopecia areata from other similar hair loss conditions, using visual checks and specific tests.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Current guidelines may overlook beard and sideburn involvement in diagnosing frontal fibrosing alopecia in men.

The treatment is a safe and effective option for hair regrowth in patchy alopecia areata.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

People with alopecia areata may be more likely to have a certain type of hearing loss.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Alopecia areata may involve disrupted mesenchymal function in hair follicles.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Adalimumab can cause complete hair loss in rare cases.

Reducing CD8+ T cell growth can stabilize alopecia areata.

A rare case of a man having both frontal fibrosing alopecia and vitiligo was reported.

A 47-year-old man was diagnosed with a specific type of hair loss and advised to use certain medications and avoid hair transplants.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

The woman has unexplained hair loss and it's unclear what her condition is or how to treat it.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Alopecia areata is more common in males, often appears as patchy hair loss, and is strongly linked to anemia.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

An Australian with rare hair loss and eye conditions had a gene linked to both, not seen together before.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

White hair regrowth in alopecia areata may be more common than thought.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Sulfasalazine may help regrow hair in severe alopecia areata cases.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Topical corticosteroids are the best initial treatment for children with Alopecia Areata.